Literature DB >> 8391202

Inhibition of the acute-phase response in a human hepatoma cell line.

J G Raynes1, S Bevan.   

Abstract

The HuH-7 human hepatoma cell line was stimulated by IL-1 and IL-6 to increase the synthesis of acute-phase proteins, e.g. serum amyloid A (SAA), alpha 1 antichymotrypsin (ACT), alpha 1-protease inhibitor, alpha 1 acid-glycoprotein and haptoglobin, with the exception of the pentraxins (serum amyloid P and C-reactive protein). Haptoglobin and ACT were stimulated by IL-1 which has not been observed in some other hepatoma cell lines. The concentration of IL-1 required for stimulation of SAA was higher than that required for haptoglobin stimulation. IL-1 receptor antagonist was capable of inhibiting these responses and acted at a lower concentration to inhibit SAA than required to inhibit ACT or haptoglobin induction. Transforming growth factor beta (TGF beta) was also able to inhibit the response to IL-1 but had no effect on acute-phase protein responses to IL-6.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391202     DOI: 10.1007/bf01991140

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

2.  Transforming growth factor beta 1 regulates production of acute-phase proteins.

Authors:  A Mackiewicz; M K Ganapathi; D Schultz; A Brabenec; J Weinstein; M F Kelley; I Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells.

Authors:  S Bevan; J G Raynes
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

4.  Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.

Authors:  C M Dubois; F W Ruscetti; E W Palaszynski; L A Falk; J J Oppenheim; J R Keller
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

5.  Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.

Authors:  M Turner; D Chantry; P Katsikis; A Berger; F M Brennan; M Feldmann
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

6.  Post-transcriptional control of negative acute phase genes by transforming growth factor beta.

Authors:  G Morrone; R Cortese; V Sorrentino
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

  6 in total
  2 in total

1.  Global assessment of GU-rich regulatory content and function in the human transcriptome.

Authors:  Anason S Halees; Edward Hitti; Maher Al-Saif; Linah Mahmoud; Irina A Vlasova-St Louis; Daniel J Beisang; Paul R Bohjanen; Khalid Khabar
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

2.  Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.

Authors:  Jürgen Borlak; Prashant Singh; Giuseppe Gazzana
Journal:  BMC Genomics       Date:  2015-02-25       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.